In a patient undergoing chemotherapy, why does aplastic anemia frequently manifest as thrombocytopenia and neutropenia in addition to erythrocyte deficiency?

💡 Explanation

Aplastic anemia, particularly in chemotherapy patients, often presents as pancytopenia because chemotherapeutic agents damage bone marrow stem cells, which are responsible for producing all blood cell lineages. Therefore, erythrocytes, thrombocytes, and neutrophils are all reduced rather than a single cell type, because of stem cell suppression.

• A patient with liver cirrhosis experiences prolonged bleeding after a minor injury. Which mechanism explains why reduced fibrin crosslinking leads to this bleeding tendency?
• Why does adaptation to high salt concentration during continuous tasting diminish perceived saltiness?
• Why does rheumatoid arthritis develop after some infections trigger antibody production that targets both the pathogen and joint tissues?
• Why does severe dehydration lead to decreased cognitive function?
• Why does neuronal damage continue even after initial aggregate formation in Huntington's disease?
• Why does chronic cocaine use typically lead to increased drug-seeking behavior even as the user experiences diminished euphoria?